Ali̇ Volkan ÖZDEMİR, Soycan MIZRAK, Hakan YILMAZ

Evaluation of the correlation of D-Dimer tests with tomographic findings in Covid-19 patients

This study seeks to evaluate the relationship between d-dimer levels and computer tomography (CT) findings at the time of the first admission to the hospital and the effect of these examinations on the hospitalization time. Our study group consists of patients who were admitted to our hospital on an outpatient basis between 1 June and 30 July and who were hospitalized and had a positive PCR covid 19 tests. Age and gender of these patients, duration of hospitalization, first plasma D-dimer levels analyzed on the day of hospitalization, and Thoracic CT severity scores were obtained from the Hospital Information Management System (HIMS) and recorded. All these data were arranged in Microsoft Office 365 EXCEL program and evaluated statistically in SPSS 21.0 program. Patients with d-dimer levels above the cut-off value at the first admission had high CT severity scores and longer hospitalization periods. Increasing the age of the patient prolongs the hospitalization. The fact that d-dimer levels above the cut-off value at the time of first application show increased lung infiltration, will reduce the need for chest tomography in the diagnosis and follow-up of covid 19.

PDF

___

1. World Health Organization. Novel coronavirus–China. Available at: https:// www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/. Accessed Apr 7, 2020.
2. Vaduganathan M, Vardeny O, Michel T et al. Renin–angiotensin– aldosterone system inhibitors in patients with Covid-19. N Engl J Med. 2020;382:1653-9.
3. Srivastava S, Garg I, Bansal A et al. COVID-19 infection and thrombosis. Clin Chim Acta. 2020;510:344–6.
4. Hoesein FM. Low-dose computed tomography instead of radiography in suspected pneumonia. Breath (Sheff).2019;15:81–3.
5. Yao Y, Cao J, Wang Q, et al. D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study. J Intensive Care. 2020;8:49.
6. Pan F, Ye T, Sun P et al. Time Course of Lung Changes at Chest CT during Recovery from Coronavirus Disease 2019 (COVID-19). Radiology. 2020; 295:3.
7. Gupta A, Madhavan M, Sehgal K et al. Extrapulmonary manifestations of COVID-19. Nature Med. 2020;26:1017–32.
8. Kany S, Vollrath J, Relja B. Cytokines in Inflammatory Disease. Int J Mol Sci. 2019;20:6008.
9. Connors JM, Levy JH. Tromboinflammation and the hypercoagulability of Covid 19. J Thromb Haemost. 2020;18:1559–61.
10. Colling M, Sun L, Upadhyay V et al. Deaths and complications associated with the management of acute immune thrombotic thrombocytopenic purpura. Transfusion. 2020;60:841-6.
11. Bilaloglu S, Aphinyanaphongs Y, Jones S et al. Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health System. JAMA. 2020; 324:799–801.
12. Marini J, Gattinoni L. Management of COVID-19 Respiratory Distress. JAMA. 2020;323:2329-30.
13. Chang TH, Wu JL, Chang LY. Clinical characteristics and diagnostic challenges of pediatric COVID-19: A systematic review and meta-analysis. J Formos Med Assoc. 2020;119:982-89.
14. Ozer PK, Govdeli E, Baykiz D et al. Impairment of right ventricular longitudinal strain associated with severity of pneumonia in patients recovered from COVID-19. Int J Cardiovasc Imaging. 2021 37:2387-97.
15. Chen Y, Klein S, Garibaldi B et al. Aging in COVID-19: Vulnerability, immunity and intervention. Ageing Res Rev. 2021;65:101205.